ALPHA-METHYL DOPA FOR THE TREATMENT OF HYPERTENSION:  CLINICAL AND PHARMACODYNAMIC STUDIES.
D000469:Alkaline Phosphatase; D000959:Antihypertensive Agents; D001663:Bilirubin; D001772:Blood Cell Count; D001786:Blood Glucose; D001794:Blood Pressure; D001795:Blood Pressure Determination; D003401:Creatine; D003404:Creatinine; D004395:Dye Dilution Technique; D004562:Electrocardiography; D005853:Geriatrics; D006801:Humans; D006973:Hypertension; D008750:Methyldopa; D009584:Nitrogen; D013448:Sulfobromophthalein; D014116:Toxicology; D014508:Urea
D000959:Antihypertensive Agents; D001786:Blood Glucose; D013448:Sulfobromophthalein; D008750:Methyldopa; D014508:Urea; D003404:Creatinine; D000469:Alkaline Phosphatase; D003401:Creatine; D009584:Nitrogen; D001663:Bilirubin
ALKALINE PHOSPHATASE; ANTIHYPERTENSIVE AGENTS; BILIRUBIN; BLOOD CELL COUNT; BLOOD PRESSURE; BLOOD SUGAR; CREATINE AND CREATININE; DYE DILUTION TECHNIC; ELECTROCARDIOGRAPHY; GERIATRICS; HYPERTENSION; METHYLDOPA; NITROGEN; SULFOBROMOPHTHALEIN; TOXICOLOGIC REPORT; UREA